Emerging Role of SIGIRR rs7396562(T/G) Polymorphism in Systemic Lupus Erythematosus in a Chinese Population

Inflammation

Volumn 37, Issue 5, 2014, Pages 1847-1851

  Zhu, Yan ^a   Wang, De Guang ^a   Yang, Xiao Ke ^a   Tao, Sha Sha ^a   Huang, Qing ^a   Pan, Hai Feng ^a   Feng, Chen Chen ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Chinese population; polymorphism; SIGIRR; systemic lupus erythematosus

Indexed keywords

IMMUNOGLOBULIN; INTERLEUKIN 1 RECEPTOR; SINGLE IMMUNOGLOBULIN INTERLEUKIN 1 RELATED RECEPTOR; UNCLASSIFIED DRUG; TIR8 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTOSENSITIVITY; RASH; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; ETHNOLOGY; GENETICS; HEALTH SURVEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PROCEDURES;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; RECEPTORS, INTERLEUKIN-1;

EID: 84918824073     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9916-z     Document Type: Article

References (25)

1. Cervera, R., M.A. Khamashta, J. Font, G.D. Sebastiani, A. Gil, P. Lavilla, J.C. Mejía, A.O. Aydintug, H. Chwalinska-Sadowska, E. de Ramón, A. Fernández-Nebro, M. Galeazzi, M. Valen, A. Mathieu, F. Houssiau, N. Caro, P. Alba, M. Ramos-Casals, M. Ingelmo, and G.R. Hughes. 2003. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82(5): 299–308.
2. Münz, C., J.D. Lünemann, M.T. Getts, and S.D. Miller. 2009. Antiviral immune responses: triggers of or triggered by autoimmunity? Nature Reviews Immunology 9(4): 246–258.
3. Takeuchi, Osamu, and Shizuo Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805–820.
4. Thomassen, E., B.R. Renshaw, and J.E. Sims. 1999. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine 11: 389–399.
5. Drexler, S.K., P. Kong, J. Inglis, R.O. Williams, C. Garlanda, A. Mantovani, A.S. Yazdi, F. Brennan, M. Feldmann, and B.M. Foxwell. 2010. SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis. Arthritis and Rheumatism 62: 2249–2261.
6. Lech, M., O.P. Kulkarni, S. Pfeiffer, E. Savarese, A. Krug, C. Garlanda, A. Mantovani, and H.J. Anders. 2008. Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens. Journal of Experimental Medicine 205: 1879–1888.
7. O’Neill, L.A. 2003. SIGIRR puts the brakes on Toll-like receptors. Nature Immunology 4: 823–824.
8. Wang, C., C.C. Feng, H.F. Pan, D.G. Wang, and D.Q. Ye. 2013. Therapeutic potential of SIGIRR in systemic lupus erythematosus. Rheumatology International 33(8): 1917–1921.
9. Garlanda, C., H.J. Anders, and A. Mantovani. 2009. TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization. Trends in Immunology 30: 439–446.
10. Wald, D., J. Qin, Z. Zhao, Y. Qian, M. Naramura, L. Tian, J. Towne, J.E. Sims, G.R. Stark, and X. Li. 2003. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nature Immunology 4(9): 920–927.
11. Garlanda, C., D. Di Liberto, A. Vecchi, M.P. La Manna, C. Buracchi, N. Caccamo, A. Salerno, F. Dieli, and A. Mantovani. 2007. Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by Toll IL-1 receptor 8/single Ig IL-1-related receptor, a negative regulator of IL-1/TLR signaling. Journal of Immunology 179(5): 3119–3125.
12. Bulek, K., S. Swaidani, J. Qin, Y. Lu, M.F. Gulen, T. Herjan, B. Min, R.A. Kastelein, M. Aronica, M. Kosz-Vnenchak, and X. Li. 2009. The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response. Journal of Immunology 182(5): 2601–2609.
13. Batliwalla, F.M., W. Li, C.T. Ritchlin, X. Xiao, M. Brenner, T. Laragione, T. Shao, R. Durham, S. Kemshetti, E. Schwarz, R. Coe, M. Kern, E.C. Baechler, T.W. Behrens, P.K. Gregersen, and P.S. Gulko. 2005. Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis. Molecular Medicine 11(1–12): 21–29.
14. Hochberg, M.C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 40(9): 1725.
15. Sauna, Z.E., and C. Kimchi-Sarfaty. 2011. Understanding the contribution of synonymous mutations to human disease. Nature Reviews Genetics 12(10): 683–691.
16. Szeto, C.C., H.Y. Mok, K.M. Chow, T.C. Lee, J.Y. Leung, E.K. Li, T.K. Tsui, S. Yu, and L.S. Tam. 2008. Climatic influence on the prevalence of noncutaneous disease flare in systemic lupus erythematosus in Hong Kong. The Journal of Rheumatology 35(6): 1031–1037.
17. Lech, M., V. Skuginna, O.P. Kulkarni, J. Gong, T. Wei, R.W. Stark, C. Garlanda, A. Mantovani, and H.J. Anders. 2010. Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis. Journal of Pathology 220(5): 596–607.
18. Lang, T., and A. Mansell. 2007. The negative regulation of Toll-like receptor and associated pathways. Immunology and Cell Biology 85(6): 425–434.
19. Andreakos, E., S.M. Sacre, C. Smith, A. Lundberg, S. Kiriakidis, T. Stonehouse, C. Monaco, M. Feldmann, and B.M. Foxwell. 2004. Distinct pathways of LPS induced NF-kappa B activation and cytokine production in human myeloid and non myeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood 103(6): 2229–2237.
20. Garlanda, C., F. Riva, N. Polentarutti, C. Buracchi, M. Sironi, M. De Bortoli, M. Muzio, R. Bergottini, E. Scanziani, A. Vecchi, E. Hirsch, and A. Mantovani. 2004. Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proceedings of the National Academy of Sciences of the United States of America 101(10): 3522–3526.
21. Gulen, M.F., Z. Kang, K. Bulek, W. Youzhong, T.W. Kim, Y. Chen, C.Z. Altuntas, K. Sass Bak-Jensen, M.J. McGeachy, J.S. Do, H. Xiao, G.M. Delgoffe, B. Min, J.D. Powell, V.K. Tuohy, D.J. Cua, and X. Li. 2010. The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity 32(1): 54–66.
22. Su, K.Y., and D.S. Pisetsky. 2009. The role of extracellular DNA in autoimmunity in SLE. Scandinavian Journal of Immunology 70(3): 175–183.
23. McAlindon, T. 2000. Update on the epidemiology of systemic lupus erythematosus: new spins on old ideas. Current Opinion in Rheumatology 12(2): 104–112.
24. Novick, D., D. Elbirt, G. Miller, C.A. Dinarello, M. Rubinstein, and Z.M. Sthoeger. 2010. High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. Journal of Autoimmunity 34(2): 121–126.
25. Lood, C., B. Gullstrand, L. Truedsson, A.I. Olin, G.V. Alm, L. Ronnblom, G. Sturfelt, M.L. Eloranta, and A.A. Bengtsson. 2009. C1q inhibits immune complex–induced interferon-α production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis and Rheumatology 60(10): 3081–3090.